Swizzard Pharma AG, a provider of support services for biotech and pharma companies in Switzerland, has appointed Jonas Mülchi as Deputy Chairman of the Board of Directors.
Jonas has a degree in Economics (major) with Business Administration and Law (minors) from the University of Bern. He has around 20 years’ experience in the financial sector, both in industry and in regulatory roles. Jonas draws on experience from various international assignments, including in Asia, the UK and the US, where he went on secondment to the Office of the Comptroller of the Currency, New York.
Jonas currently works for the State Secretariat for International Finance. As senior policy advisor, he is involved in developing the legal frameworks for large financial institutions.
Previously, Jonas worked at the Swiss Financial Market Supervisory Authority (FINMA) for eleven years, where he was responsible for the oversight of Swiss too-big-to-fail banks. During his time there, he gained a broad understanding of the regulatory landscape in banking and the requirements on risk management and corporate governance.
In his nine-year tenure at Credit Suisse he worked his way up to the role of Vice President. Jonas led teams of different sizes with a focus on capital requirement calculation and reporting.
“I’m looking forward to bringing my regulatory and oversight expertise to a new field of activity for Swizzard,” says Jonas Mülchi.
“With his expertise in Corporate Finance, Corporate Governance and Risk Management, Jonas brings a complementary skill set to Swizzard and our clients,” says Michael Zürcher, CEO of Swizzard. “We’re excited to have him on board and wish him every success in his new role at Swizzard.”
